The Grow Access Project aims to reduce the barrier to entry for prescribed cannabis medicines for patients on low-income or disability benefits, veterans of UK armed forces, Blue Light Card holders, and UK University Students. GROW's aim is to constantly improve the accessibility of cannabis medicines across the globe.
1. Those on benefits:
Includes all means-tested benefits, and PIP. Confirmed via confirmation letter or screenshot of your benefits portal.
2. UK Veterans
Confirmed via a Veterans ID Card.
3. Blue Light Card Holders
Confirmed via your Blue Light Card.
4. University Students
Confirmed via your Student ID Card.
The GAP provides reduced cost-related barriers for certain groups. This means that you can find out if you're eligible for a prescription, what medicine you need and the cost of these medicines before paying anything! This includes:
1.Reduced costs of certain medicines
Available at any UK clinic, when prescriptions are sent to IPS Pharma
2.Free First Appointment and reduced repeat prescription fees
Available only at Integro Clinics.
There are two ways to access the scheme:
If you would like to become a patient at Integro Clinics, please contact their team.
If you are with another clinic and would like to access GAP, this can be done by asking your doctor for your prescription to be sent to IPS Pharma and marked/stamped as “GAP”.
If you have any questions regarding the GAP, please email [email protected]
Here you can find out exactly how to get a prescription for Medical Cannabis in the UK.
GROW medicines can be accessed by all clinics in the UK, with increasing availability across Germany and other markets as we expand our network. In the development of GROW Iberia, we are ensuring the continued refinement of our product offering, with access to the products that patients want and need in all our markets.
There is a wide range of unlicensed cannabis-based products available, including oils and dried flowers, produced in line with good manufacturing practices and available for prescription.
GROW leads the way in unlocking the potential of cannabis medicines, ensuring that as many patients as possible have access to the most beneficial products.We are already helping over 3,000 patients in the UK, representing nearly 50% of those receiving cannabis medicines in the UK. There is every confidence that this patient group will expand as we continue to invest in research and development.
We are always here to help. If you have a question, comment or want to learn more please fill in your details below and one of our team members will contact you.